Heather Devantier is currently a Director of Program Management at Eli Lilly and Company, where they lead research project teams and collaborations in genetic medicine. With a strong foundation in strategic program management developed over years at various biotechnology firms, Heather previously drove pivotal projects, including a phase 3 trial at Frequency Therapeutics. They hold a Master’s degree in Cell and Developmental Biology from Rutgers Robert Wood Johnson Medical School and an MBA in Entrepreneurship and Innovation from Drexel University, alongside a BS in Biology from Temple University. Earlier roles included positions at Pfizer, Takeda Oncology, and Schering-Plough Research Institute, where Heather demonstrated a commitment to collaborative success and innovation in the biotechnology sector.
This person is not in any teams
This person is not in any offices